70842-04-5

Basic information

• Product Name: 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin
• Synonyms: 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin;3-(4-Fluoro-3-(Trifluoromethyl)Phenyl)-5,5-Dimethylimidazolidine-2,4-Dione;3-(4-Fluoro-3-(Trifluoromethyl)Phenyl)-5,5-Dimethylimidazolidine-2,4-Dione(WXC01722)
• CAS NO: 70842-04-5
• Molecular Formula: C₁₂H₁₀F₄N₂O₂
• Molecular Weight: 290.21
• Mol File: 70842-04-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Density: 1.387g/cm³
• Refractive Index: 1.483
• CAS DataBase Reference: 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin(CAS DataBase Reference)
• NIST Chemistry Reference: 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin(70842-04-5)
• EPA Substance Registry System: 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin(70842-04-5)

Safety Data

• Hazardous Substances Data: 70842-04-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C12H10F4N2O2/c1-11(2)9(19)18(10(20)17-11)6-3-4-8(13)7(5-6)12(14,15)16/h3-5H,1-2H3,(H,17,20)

Upstream product

• 70842-08-9 5-Imino-4,4-dimethyl-1-(α,α,α,4-tetrafluor-m-tolyl)-2-imidazolidinon 
• 15028-41-8 methyl 2-aminoisobutyrate hydrochloride 
• 2357-47-3 4-Fluoro-3-trifluoromethylaniline 
• 77140-72-8 α,α,α,4-Tetrafluor-m-tolylcarbamidsaeurephenylester 
• 54213-21-7 α-Isocyanatobuttersaeure-methylester 
• 92668-50-3 2-[3-(4-Fluoro-3-trifluoromethyl-phenyl)-ureido]-2-methyl-propionic acid methyl ester 

Downstream Products

• 92668-48-9 1-Chlor-5,5-dimethyl-3-(α,α,α,4-tetrafluor-m-tolyl)hydantoin 
• 92668-59-2 5,5-Dimethyl-1-nitro-3-(α,α,α,4-tetrafluor-m-tolyl)hydantoin 
• 1179905-58-8 3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-1-(3-pentafluorosulfanyl-benzyl)imidazolidine-2,4-dione 
• 1179906-55-8 methyl 2-(3-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}ureido)-2-methylpropionate 
• 1179804-28-4 4-{2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]benzoyl}benzoic acid 
• 1179804-26-2 methyl 4-{2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]benzoyl}benzoate 
• 1179329-52-2 1-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}-3-(4-methanesulfonylphenyl)sulfamide 
• 1179329-83-9 N-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}N'-tert-butyloxycarbonylsulfamide 
• 1179329-42-0 monoethyl [4-(3-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}ureido)phenyl]phosphonate 
• 1179329-84-0 N-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}sulfamide 
• 1179329-43-1 [4-(3-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}ureido)phenyl]phosphonic acid 
• 1179329-41-9 diethyl [4-(3-{5-fluoro-2-[3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-ylmethyl]phenyl}ureido)phenyl]phosphonate 
• 1006899-36-0 1-(2-amino-4-fluorobenzyl)-3-(4-fluoro-3-trifluoromethyl-phenyl)-5,5-dimethylimidazolidine-2,4-dione 
• 1179329-96-4 1-(4,5-dimethoxy-2-nitrobenzyl)-3-(4-fluoro-3-trifluoromethylphenyl)-5,5-dimethylimidazolidine-2,4-dione 

Relevant articles and documents

Heterocycle-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising them and use thereof

The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.

Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof

The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.

Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use

This invention relates to arylaminoaryl-alkyl-substituted imidazolidone-2,4-diones of formula (I) and also to their physiologically tolerated salts: Wherein R, R′, R1 to R10, A, D, E, G, L and p are as defined herein. The invention also relates to processes for preparing them, pharmaceutical compositions comprising them and their therapeutic use. The compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome.